For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in high-risk patients, sending drug industry stocks soaring. WSJ’s Xavier Martinez traces Moderna’s wild ride from scrappy startup to the frontier of can treatment. Ryan Knutson hosts.
Further Listening:
- The FDA Commissioner on Vaccines and Public Trust
- The Creator of the Record-Setting Covid Vaccine
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Soyez le premier à commenter ce contenu.
Connectez-vous à votre compte Podmust pour commenter.
Se connecterThe most important stories, explained through the lens of business. A podcast about money, business and power. Hosted by Kate Linebaugh and Ryan Knutson. The Journal is a co-production from Spotify and The Wall Street Journal.
Click here to discover another podcast randomly, or here to browse our categories. Lazy? That's okay, we did some research and selected podcasts just for you.
Podmust is a french project aiming to promote the best podcasts. You can help us by sharing this page (this also helps the podcast, by the way). Thank you! 🙏
Podmust curates what you need to listen.
Discover some of our collections:
our best Music podcastsour best Sports & Recreation podcastsour best Business podcasts.
Well, the bad news is: we're French. But the good news is: Podmust curates the world's podcasts so you can focus on staying informed or entertained. And voilà!
© Podmust